» Articles » PMID: 33586908

Nerve Growth Factor (NGF) and NGF Receptors in Mesenchymal Stem/stromal Cells: Impact on Potential Therapies

Overview
Date 2021 Feb 15
PMID 33586908
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Mesenchymal stem/stromal cells (MSCs) are promising for the treatment of degenerative diseases and traumatic injuries. However, MSC engraftment is not always successful and requires a strong comprehension of the cytokines and their receptors that mediate the biological behaviors of MSCs. The effects of nerve growth factor (NGF) and its two receptors, TrkA and p75NTR, on neural cells are well studied. Increasing evidence shows that NGF, TrkA, and p75NTR are also involved in various aspects of MSC function, including their survival, growth, differentiation, and angiogenesis. The regulatory effect of NGF on MSCs is thought to be achieved mainly through its binding to TrkA. p75NTR, another receptor of NGF, is regarded as a novel surface marker of MSCs. This review provides an overview of advances in understanding the roles of NGF and its receptors in MSCs as well as the effects of MSC-derived NGF on other cell types, which will provide new insight for the optimization of MSC-based therapy.

Citing Articles

Engineered Extracellular Vesicles from Antler Blastema Progenitor Cells: A Therapeutic Choice for Spinal Cord Injury.

Yang S, Xue B, Zhang Y, Wu H, Yu B, Li S ACS Nano. 2025; 19(6):5995-6013.

PMID: 39841785 PMC: 11841045. DOI: 10.1021/acsnano.4c10298.


Single-cell transcriptome analysis of stem cells from human exfoliated deciduous teeth investigating functional heterogeneity in immunomodulation.

Li Y, Song G, Jiang Y, Zhao H, Zhu Y, Song S Sci Rep. 2024; 14(1):31279.

PMID: 39732760 PMC: 11682124. DOI: 10.1038/s41598-024-82734-8.


Comparative analysis of the effects of different hypoxia mimetic agents on the secretome contents of conditioned medium obtained from mesenchymal stem/stromal cells cultured in 2 or 3-dimensional cell culture systems.

Ozkan S, Isildar B, Koyuturk M Cytotechnology. 2024; 77(1):11.

PMID: 39654545 PMC: 11625095. DOI: 10.1007/s10616-024-00659-6.


Effects of mesenchymal stromal cells and human recombinant Nerve Growth Factor delivered by bioengineered human corneal lenticule on an innovative model of diabetic retinopathy.

Pelusi L, Hurst J, Detta N, Pipino C, Lamolinara A, Conte G Front Endocrinol (Lausanne). 2024; 15:1462043.

PMID: 39473506 PMC: 11518713. DOI: 10.3389/fendo.2024.1462043.


The Use of Neurotrophic Factors as a Promising Strategy for the Treatment of Neurodegenerative Diseases (Review).

Fursa G, Andretsova S, Shishkina V, Voronova A, Karsuntseva E, Chadin A Bull Exp Biol Med. 2024; 177(4):517-527.

PMID: 39266924 DOI: 10.1007/s10517-024-06218-5.


References
1.
Aurikko J, Ruotolo B, Grossmann J, Moncrieffe M, Stephens E, Leppanen V . Characterization of symmetric complexes of nerve growth factor and the ectodomain of the pan-neurotrophin receptor, p75NTR. J Biol Chem. 2005; 280(39):33453-60. PMC: 1352310. DOI: 10.1074/jbc.M503189200. View

2.
Sadraddin H, Gaebel R, Skorska A, Lux C, Sasse S, Ahmad B . CD271 Human Mesenchymal Stem Cells Show Antiarrhythmic Effects in a Novel Murine Infarction Model. Cells. 2019; 8(12). PMC: 6953053. DOI: 10.3390/cells8121474. View

3.
Pevsner-Fischer M, Levin S, Zipori D . The origins of mesenchymal stromal cell heterogeneity. Stem Cell Rev Rep. 2011; 7(3):560-8. DOI: 10.1007/s12015-011-9229-7. View

4.
Yuan W, Ibanez C, Lin Z . Death domain of p75 neurotrophin receptor: a structural perspective on an intracellular signalling hub. Biol Rev Camb Philos Soc. 2019; 94(4):1282-1293. DOI: 10.1111/brv.12502. View

5.
Troullinaki M, Alexaki V, Mitroulis I, Witt A, Ameln A, Chung K . Nerve growth factor regulates endothelial cell survival and pathological retinal angiogenesis. J Cell Mol Med. 2019; 23(4):2362-2371. PMC: 6433692. DOI: 10.1111/jcmm.14002. View